Sun Pharma reports Q4 earnings.

◼️#US sales at $430 m, up 10.5% (YoY)

◼️Global #specialty sales at $244 m, Up 28% (YoY)

◼️India #formulation sales at Rs 3,364.1 cr, up 8.7% (YoY)

◼️Emerging Markets (#EMs) formulation #sales at $221 m, up 7.5% (YoY)